Cargando…
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Autores principales: | Mairhofer, Mario, Kausche, Lea, Kaltenbrunner, Sabine, Ghanem, Riad, Stegemann, Maike, Klein, Katharina, Pammer, Maria, Rauscher, Isabella, Salzer, Helmut J.F., Doppler, Stefan, Habringer, Anna, Paar, Christian, Kimeswenger, Susanne, Hoetzenecker, Wolfram, Lamprecht, Bernd, Lee, Soyoung, Schmitt, Clemens A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367743/ https://www.ncbi.nlm.nih.gov/pubmed/34450047 http://dx.doi.org/10.1016/j.ccell.2021.08.001 |
Ejemplares similares
-
Emerging COVID-19 reinfection four months after primary SARS-CoV-2 infection
por: Salzer, Helmut J. F., et al.
Publicado: (2021) -
Nontuberculous Mycobacterial Pulmonary Disease from Mycobacterium hassiacum, Austria
por: Salzer, Helmut J.F., et al.
Publicado: (2020) -
Cutaneous manifestations of SARS-CoV-2: A 2-center, prospective, case-controlled study
por: Unterluggauer, Luisa, et al.
Publicado: (2021) -
DLBCL 1L—What to Expect beyond R-CHOP?
por: Stegemann, Maike, et al.
Publicado: (2022) -
Minimally invasive autopsies for the investigation of pulmonary pathology of COVID-19—experiences of a longitudinal series of 92 patients
por: Noack, Petar, et al.
Publicado: (2023)